204318-14-9(DOTA-D-PHE-CYS-TYR-D-TRP-LYS-THR-CYS-THR-OL (DISULFIDE BRIDGE: 2-7))
Product Description
204318-14-9
CAS No.
204318-14-9
Chemical Name:
DOTA-D-PHE-CYS-TYR-D-TRP-LYS-THR-CYS-THR-OL (DISULFIDE BRIDGE: 2-7)
CBNumber:
CB2293419
Molecular Formula:
C65H92N14O18S2
Formula Weight:
1421.65
MOL File:
Mol file
DOTA-D-PHE-CYS-TYR-D-TRP-LYS-THR-CYS-THR-OL (DISULFIDE BRIDGE: 2-7) Synonyms:
DOTA-[TYR3]-OCTREOTIDE
DOTATOC
DOTA-FCYWKTCT-OL (DISULFIDE BRIDGE: 2-7)
DOTA-D-PHE-CYS-TYR-D-TRP-LYS-THR-CYS-THR-OL (DISULFIDE BRIDGE: 2-7)
[DOTA-DPHE1, TYR3]OCTREOTIDE
DOTA-D-PHE-CYS-TYR-D-TRP-LYS-THR-CYS-THREONINOL
EDOTREOTIDE
4,7,10-TRICARBOXYMETHYL-1,4,7,10-TETRAAZA-CYCLODODECAN-1-YL-ACETYL-D-PHE-CYS-TYR-D-TRP-LYS-THR-CYS-L-THREONINOL, (DISULFIDE BOND)
DOTA-D-PHE-CYS-TYR-D-TRP-LYS-THR-CYS-THR-OL (DISULFIDE BRIDGE: 2-7)
Property
alpha
22D -14.75° (c = 0.52 in 95% acetic acid)
Boiling point:
1723.7±65.0 °C(Predicted)
Density
1.46±0.1 g/cm3(Predicted)
pka
1.83±0.10(Predicted)
form
Solid
color
White to off-white
Sequence
DOTA-D-Phe-Cys-Tyr-D-Trp-Lys-Thr-Cys-Threoninol (Disulfide bridge Cys2-Cys7)
Safety
DOTA-D-PHE-CYS-TYR-D-TRP-LYS-THR-CYS-THR-OL (DISULFIDE BRIDGE: 2-7)
Suppliers
Global( 84)Suppliers
China 77
France 1
United States 6
Global 84
Supplier
Tel
Email
Country
ProdList
Advantage
Nanchang Tianzhen Biotechnology Co., Ltd
pomy@tanzhenbio.com
China
1779
58
Hangzhou Beiputai Biopharmaceutical Co., Ltd
0571-85350119
bptsales@163.com
China
3850
58
Alfa Chemistry
Info@alfa-chemistry.com
United States
24072
58
Watson Biotechnology Co.,Ltd
+86-18186686046
sales01@watsonbiotech.cn
China
5863
58
Chengdu Youngshe Chemical Co., Ltd.
+86-17380623303
Caroline@youngshechem.com
China
4900
58
Hubei Moco Chemical Co., Ltd.
3001071511@qq.com
China
10986
58
Molcoo Chemicals Inc.
3001051413@qq.com
China
9249
58
Hubei wei shi reagent group ltd., company
027-02759101766
2853877621@qq.com
China
4214
58
204318-14-9(DOTA-D-PHE-CYS-TYR-D-TRP-LYS-THR-CYS-THR-OL (DISULFIDE BRIDGE: 2-7))
Related Search:
DOTA-[TYR3]-OCTREOTIDE
DOTATOC
DOTA-FCYWKTCT-OL (DISULFIDE BRIDGE: 2-7)
DOTA-D-PHE-CYS-TYR-D-TRP-LYS-THR-CYS-THR-OL (DISULFIDE BRIDGE: 2-7)
[DOTA-DPHE1, TYR3]OCTREOTIDE
DOTA-D-PHE-CYS-TYR-D-TRP-LYS-THR-CYS-THREONINOL
EDOTREOTIDE
4,7,10-TRICARBOXYMETHYL-1,4,7,10-TETRAAZA-CYCLODODECAN-1-YL-ACETYL-D-PHE-CYS-TYR-D-TRP-LYS-THR-CYS-L-THREONINOL, (DISULFIDE BOND)
DOTA-D-Phe-Cys-Tyr-D-Trp-Lys-Thr-Cys-Threoninol (Disulfide bridge Cys2-Cys7)
EDOTREOTIDUM
L-Cysteinamide, N-[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-Lthreonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (2)-disulfide
DOTA-TOC204318-14-9
2-[4-[2-[[(2R)-1-[[(4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-4-[[(2R,3R)-1,3-dihydroxybutan-2-yl]carbamoyl]-7-[(1R)-1-hydroxyethyl]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicos-19-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-2-oxoethyl]-7,10-bis(carboxymethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetic acid
DOTA-D-PHE-CYS-TYR-D-TRP-LYS-THR-CYS-THR-OL (DISULFIDE BRIDGE: 2-7)DOTA-D-PHE-CYS-TYR-D-TRP-LYS-THR-CYS-THR-OL (DISULFIDE BRIDGE: 2-7)
L-Cysteinamide, N-[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (2→7)-disulfide
SMT 487
SMT487
SMT-487
somatostatin,DOTATOC,Edotreotide,inhibit,cancer,Inhibitor,radionuclides,SDZ-SMT 487
DOTA-(Tyr3)-Octreotide acetate salt
DOTA-(Tyr?)-Octreotide acetate salt
NOTA-TOC
DOTA-[Tyr3]Octreotide, DOTA-TOC, Edotreotide
204318-14-9
C65H92N14O18S2
peptide
Copyright 2017 © ChemicalBook. All rights reserved